, Tracking Stock Market Picks
Enter Symbol:
Concert Pharmaceuticals Inc. (CNCE) [hlAlert]

up 3.79 %

Concert Pharmaceuticals Inc. (CNCE) rated Buy with price target $25 by UBS

Posted on: Monday,  Mar 10, 2014  11:25 AM ET by UBS

UBS rated Buy Concert Pharmaceuticals Inc. (NASDAQ: CNCE) on 03/10/2014, when the stock price was $15.02. Since
then, Concert Pharmaceuticals Inc. has gained 3.79% as of 09/22/2015's recent price of $15.59.
If you would have followed this UBS's recommendation on CNCE, you would have gained 3.79% of your investment in 561 days.

UBS is the leading global wealth manager, a top tier investment banking and securities firm, and one of the largest global asset managers. In Switzerland, UBS is the market leader in retail and commercial banking. With headquarters in Zurich and Basel, Switzerland, UBS operates in over 50 countries and from all major international centers. UBS employs more than 80,000 people.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/10/2014 11:25 AM Buy
15.02 25.00
as of 10/17/2014
1 Week up  8.13 %
1 Month down  -2.61 %
3 Months up  61.41 %
1 YTD down  -10.58 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy